AI ScreeningAI ChatPricing
  1. US-listed companies
  2. Akari Therapeutics Plc
  3. Financials
  4. Return on equity (%)

Akari Therapeutics Plc【AKTX】

Market cap
$16.5B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2024-179.9-85.96%
Dec 31, 2023-1,281.6+165.21%
Dec 31, 2022-483.2+107.16%
Dec 31, 2021-233.3-48.03%
Dec 31, 2020-448.8-82.44%
Dec 31, 2019-2,555.3+1472.42%
Dec 31, 2018-162.5+17.65%
Dec 31, 2017-138.1+215.29%
Dec 31, 2016-43.8-74.10%
Dec 31, 2015-169.2-6.47%
Dec 31, 2014-180.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)